Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M294Revenue $M8.3Net Margin (%)-1,101.9Z-Score-2.3
Enterprise Value $M151EPS $-1.0Operating Margin %-1,106.1F-Score3
P/E(ttm))0Cash Flow Per Share $-1.2Pre-tax Margin (%)-1,101.9Higher ROA y-yN
Price/Book2.610-y EBITDA Growth Rate %0Quick Ratio10.7Cash flow > EarningsY
Price/Sales35.55-y EBITDA Growth Rate %0Current Ratio10.7Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-48.9Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-54.3Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M87.8ROI % (ttm)-45.0Gross Margin Increase y-yN

Gurus Latest Trades with RIGL

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
RIGLGeorge Soros 2011-12-31 Sold Out -0.0019%$6.68 - $8.3
($7.59)
$ 3.34-127%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RIGL is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


RIGL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
VANCE DOLLYEVP Corp. Affairs, G.C., Sect. 2014-12-18Sell1,000$2.2250.9view
VANCE DOLLYEVP Corp. Affairs, G.C., Sect. 2014-12-18Sell1,000$2.2250.9view
PAYAN DONALD GEVP, Pres. Discovery&Research 2014-09-03Sell20,000$2.5630.86view
PAYAN DONALD GEVP, Pres. Discovery&Research 2014-02-24Sell20,000$3.71-9.7view
BVF PARTNERS L P/IL10% Owner 2013-11-19Sell484,622$2.6426.89view
BVF PARTNERS L P/IL10% Owner 2013-06-07Buy32,700$3.47-3.46view
VANCE DOLLYEVP Corp. Affairs, G.C., Sect. 2012-09-13Sell4,151$10.43-67.88view
Maynard Ryan DEVP & CFO 2012-09-12Sell23,302$10.67-68.6view
Maynard Ryan DEVP & CFO 2012-09-10Sell51,698$10.54-68.22view
Maynard Ryan DEVP & CFO 2012-08-07Sell1,700$10.61-68.43view

Press Releases about RIGL :

    Quarterly/Annual Reports about RIGL:

    News about RIGL:

    Articles On GuruFocus.com
    Biocept (BIOC) Soars on Liquid Biopsy Appreciation, Rigel Pharmaceuticals (RIGL) Mega-deal with Bris Feb 23 2015 
    Rigel Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 01 2011 


    More From Other Websites
    Should Rigel Pharmaceuticals (RIGL) Be On Your Radar Now? - Tale of the Tape Mar 26 2015
    Why Rigel Pharmaceuticals (RIGL) Could Be Positioned for a Surge? - Tale of the Tape Mar 23 2015
    RIGEL PHARMACEUTICALS INC Financials Mar 11 2015
    Rigel Announces Fourth Quarter and Year End 2014 Financial Results Mar 10 2015
    10-K for Rigel Pharmaceuticals, Inc. Mar 05 2015
    Rigel (RIGL) Down on Wider Q4 Loss, Revenues Increase Y/Y - Analyst Blog Mar 04 2015
    RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Mar 03 2015
    RIGEL PHARMACEUTICALS INC Files SEC form 10-K, Annual Report Mar 03 2015
    Rigel reports 4Q loss Mar 03 2015
    Rigel reports 4Q loss Mar 03 2015
    Rigel Announces Fourth Quarter and Year End 2014 Financial Results Mar 03 2015
    Rigel Pharmaceuticals (RIGL) Shares March Higher, Can It Continue? - Tale of the Tape Mar 03 2015
    Rigel Pharma CEO pulls back the curtain on drug deal with Bristol-Myers Feb 26 2015
    Bristol-Myers to Buy Flexus, Team Up with Rigel - Analyst Blog Feb 24 2015
    BUZZ-U.S. STOCKS ON THE MOVE-Boeing, Digital Ally, Home Loan Servicing Feb 23 2015
    BUZZ-U.S. STOCKS ON THE MOVE-Rigel, oil stocks, Boeing Feb 23 2015
    Is Rigel Getting Enough From Bristol-Meyers? Feb 23 2015
    Rigel and Bristol-Myers Squibb Announce Research and Development Collaboration for TGF Beta Receptor... Feb 23 2015
    Rigel and Bristol-Myers Squibb Announce Research and Development Collaboration for TGF Beta Receptor... Feb 23 2015
    Rigel and Bristol-Myers Squibb Announce Research and Development Collaboration for TGF Beta Receptor... Feb 23 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK